Conditions Causing Bone Fragility and Arthritis in a 54-Year-Old Woman
In a 54-year-old woman presenting with tendon tears, retrocalcaneal bursitis, and possible fracture, the primary conditions to consider are rheumatoid arthritis (which causes both inflammatory arthritis and secondary osteoporosis), primary postmenopausal osteoporosis, and less commonly, chronic brucellosis or hyperparathyroidism.
Primary Differential Diagnoses
Rheumatoid Arthritis with Secondary Osteoporosis
Rheumatoid arthritis is the most likely unifying diagnosis that explains both the arthritis and bone fragility in this clinical scenario 1, 2. RA creates a triple threat for osteoporosis in this age group:
- Chronic inflammation directly activates osteoclasts and accelerates bone loss 1
- Glucocorticoid treatment (if used) independently causes secondary osteoporosis 1
- Age-related bone loss compounds the problem in perimenopausal/postmenopausal women 1
The retrocalcaneal bursitis is particularly suggestive, as this specific finding is well-documented in RA patients 2, 3. MRI findings in RA-associated retrocalcaneal bursitis show obliteration of the normal radiolucency and Achilles tendon thickening beyond 8mm 3. The combination of tendon tears, bursitis, and fragility fractures strongly points toward an inflammatory arthropathy affecting both joints and bone.
Primary Postmenopausal Osteoporosis
At 54 years old, this woman is in the perimenopausal/early postmenopausal window where primary osteoporosis becomes prevalent 4. The USPSTF 2025 guidelines recommend screening women under 65 who have risk factors using a two-step approach 4:
- Identify risk factors: low body weight, parental hip fracture history, smoking, excess alcohol, menopausal status
- Use clinical risk assessment tools to estimate fracture risk if risk factors present
However, primary osteoporosis alone would not explain the inflammatory features (retrocalcaneal bursitis, tendon tears).
Other Secondary Causes to Consider
Hyperparathyroidism is specifically mentioned as a risk factor for tendon injuries and can cause both bone fragility and periarticular pathology 5. Check serum calcium and PTH levels.
Chronic brucellosis, while rare in non-endemic areas, can cause the exact constellation of findings: arthritis, bursitis, tendon rupture, and bone involvement 6. Bone-joint involvement occurs in 10-85% of brucellosis cases 6. Consider if there is exposure history to unpasteurized dairy or endemic area travel. Wright agglutination testing is diagnostic 6.
Diabetes (particularly insulin-treated) increases risk for both osteoporosis and tendon pathology 5.
Diagnostic Algorithm
Step 1: Inflammatory vs. Non-inflammatory
- Check inflammatory markers: ESR, CRP, rheumatoid factor, anti-CCP antibodies
- If elevated with symmetric joint involvement: RA is highly likely 2
- If normal: consider primary osteoporosis or metabolic causes
Step 2: Assess Bone Fragility
- DXA scan at hip and lumbar spine is the gold standard screening test 4
- T-score ≤-2.5 confirms osteoporosis 4
- Check for secondary causes: serum calcium, PTH, TSH, vitamin D, complete metabolic panel
Step 3: Imaging of Affected Sites
- MRI is most accurate for retrocalcaneal bursitis, tendon tears, and occult fractures 5, 7
- Look for Kager's triangle effacement and edema (predictive of retrocalcaneal bursitis) 7
- Achilles tendon thickness >8mm suggests tendinitis 3
Step 4: Consider Infectious Causes if Atypical
- Brucella serology (Wright test) if fever, endemic exposure, or atypical presentation 6
Critical Pitfalls to Avoid
- Don't attribute everything to "osteoporosis" without investigating inflammatory causes—the combination of bursitis and tendon tears suggests systemic inflammatory disease
- Don't miss secondary osteoporosis causes—check calcium, PTH, and thyroid function
- Don't delay RA diagnosis—early treatment prevents joint destruction and reduces fracture risk 1
- Don't forget brucellosis in the differential—it can mimic RA but requires antibiotic therapy, not immunosuppression 6
Treatment Implications Based on Diagnosis
If Rheumatoid Arthritis
- Initiate DMARD therapy to control inflammation and reduce osteoclast activation 1
- Pharmacological osteoporosis treatment is indicated: alendronate or risedronate are first-line agents 8
- Ensure calcium 1000-1200mg/day and vitamin D 800 IU/day 8
- Avoid high-dose glucocorticoids when possible 1
If Primary Osteoporosis
- For postmenopausal women with fragility fracture, immediate pharmacological treatment is warranted 8
- Alendronate or risedronate first-line; zoledronic acid if adherence concerns 8
- Address modifiable risk factors: smoking cessation, limit alcohol 8